| 1 |
19904008 | Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism--an in vitro study. | 2009 Sep-Oct |
1 |
| 2 |
15199661 | Some aspects of genetic polymorphism in the biotransformation of antidepressants. | 2004 Jan-Feb |
1 |
| 3 |
11714871 | Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. | 2001 Dec |
1 |
| 4 |
9490065 | Delayed ontogenesis of CYP1A2 in the human liver. | 1998 Feb 1 |
1 |
| 5 |
9868741 | Fluvoxamine is a potent inhibitor of the metabolism of caffeine in vitro. | 1998 Dec |
2 |
| 6 |
9084457 | Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4. | 1997 Mar |
2 |
| 7 |
9324197 | Possible interaction between imipramine and butalbital. | 1997 Sep-Oct |
1 |
| 8 |
9351907 | Metabolism of the antiandrogenic drug (Flutamide) by human CYP1A2. | 1997 Nov |
2 |
| 9 |
9505989 | Olanzapine: interaction study with imipramine. | 1997 Oct |
1 |
| 10 |
7640151 | Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphisms--a population study. | 1995 Apr |
1 |
| 11 |
8846618 | Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6. | 1995 |
1 |
| 12 |
8846619 | Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2. | 1995 |
2 |
| 13 |
8466541 | Fluvoxamine is a potent inhibitor of cytochrome P4501A2. | 1993 Mar 24 |
1 |